Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Amyloidosis 1

Interventions

Ifosfamide 12Filgrastim 12Carboplatin 12Peripheral Blood Stem Cell Transplantation 11Etoposide 11Paclitaxel 9Cyclophosphamide 7Cisplatin 6Thiotepa 4Flow Cytometry 4Radiotherapy 3Immunologic Techniques 3pegfilgrastim 2etoposide phosphate 2Vinblastine 2Temozolomide 2Microarray Analysis 2Methylprednisolone 2Busulfan 2Alemtuzumab 2guadecitabine 1fludarabine phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1Topotecan 1Tacrolimus 1Sunitinib 1Psychiatric Rehabilitation 1Prednisone 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Testicular Germ Cell Tumor × In Situ Hybridization × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡